Using vaccine-induced immunity from stem cell donors to protect transplant recipients from virus reactivation
Transfer of vaccine-induced immunity from immunocompetent stem cell donor as antiviral immunotherapy to protect high-risk transplant recipients from cytomegalovirus reactivation
['FUNDING_R01'] · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · NIH-11094840
This study is looking at whether giving stem cell transplant patients cells from donors who have been vaccinated against cytomegalovirus (CMV) can help keep them safe from getting sick from this virus after their transplant.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE (nih funded) |
| Locations | 1 site (DUARTE, UNITED STATES) |
| Trial ID | NIH-11094840 on ClinicalTrials.gov |
What this research studies
This research investigates how transferring immunity from vaccinated stem cell donors can help protect high-risk transplant recipients from cytomegalovirus (CMV) reactivation. The approach involves vaccinating the stem cell donors with a modified vaccine that targets CMV, which has shown promising results in preliminary studies. By enhancing the immune response in donors, the goal is to improve outcomes for transplant recipients who are at risk of developing CMV-related complications. Patients participating in this research may receive stem cells from vaccinated donors, potentially leading to better protection against CMV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are high-risk transplant recipients, particularly those receiving stem cells from vaccinated donors.
Not a fit: Patients who are not undergoing stem cell transplantation or those who do not have a risk of CMV reactivation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the risk of CMV reactivation in transplant recipients, improving their overall health outcomes.
How similar studies have performed: Previous studies have shown success with similar approaches, particularly in enhancing immunity through vaccination in transplant settings.
Where this research is happening
DUARTE, UNITED STATES
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — DUARTE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DIAMOND, DON J — BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
- Study coordinator: DIAMOND, DON J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.